Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bert Klebl

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Iscience|February 2, 2024
Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonistsLukša Popović, Jan P Wintgens, Yuxin Wu, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2017
Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell-based Compound Discovery and Target PredictionLea Kremer, Carsten Schultz-Fademrecht, Matthias Baumann, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2005
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivativesZsolt Székelyhidi, János Pató, Frigyes Wáczek, et al.
Therapeutic Advances in Hematology|October 29, 2020
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemiaPatricia Johansson, Laura Dierichs, Ludger Klein-Hitpass, et al.
Frontiers in Immunology|May 1, 2025
The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigmRobert Hoffrogge, Anna Karachunskaya, Neele Heitmann, et al.
Science Immunology|August 26, 2018
Gasdermin D plays a vital role in the generation of neutrophil extracellular trapsGabriel Sollberger, Axel Choidas, Garth Lawrence Burn, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrationsCorina Hutterer, Jan Eickhoff, Jens Milbradt, et al.
Virus Research|August 17, 2023
Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiencyMartin Schütz, Christina Wangen, Mona Sommerer, et al.
Chemmedchem|March 8, 2023
A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti-Tuberculosis Properties of Moiramide BIrina Kollmorgen, Nathalie Bachmann, Michael Dal Molin, et al.
Microlife|December 24, 2025
Glucose metabolism controls oxidative burst and lipid mediator production in neutrophils upon microbial challengeAlexandra Freitag, Kerstin Günther, Miriam Campillo Prados, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Iscience|February 2, 2024
Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonistsLukša Popović, Jan P Wintgens, Yuxin Wu, et al.
Angewandte Chemie (International Ed. in English)|August 24, 2017
Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell-based Compound Discovery and Target PredictionLea Kremer, Carsten Schultz-Fademrecht, Matthias Baumann, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2005
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivativesZsolt Székelyhidi, János Pató, Frigyes Wáczek, et al.
Therapeutic Advances in Hematology|October 29, 2020
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemiaPatricia Johansson, Laura Dierichs, Ludger Klein-Hitpass, et al.
Frontiers in Immunology|May 1, 2025
The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigmRobert Hoffrogge, Anna Karachunskaya, Neele Heitmann, et al.
Science Immunology|August 26, 2018
Gasdermin D plays a vital role in the generation of neutrophil extracellular trapsGabriel Sollberger, Axel Choidas, Garth Lawrence Burn, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrationsCorina Hutterer, Jan Eickhoff, Jens Milbradt, et al.
Virus Research|August 17, 2023
Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiencyMartin Schütz, Christina Wangen, Mona Sommerer, et al.
Chemmedchem|March 8, 2023
A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti-Tuberculosis Properties of Moiramide BIrina Kollmorgen, Nathalie Bachmann, Michael Dal Molin, et al.
Microlife|December 24, 2025
Glucose metabolism controls oxidative burst and lipid mediator production in neutrophils upon microbial challengeAlexandra Freitag, Kerstin Günther, Miriam Campillo Prados, et al.
Pageof 6